Boehringer Ingelheim Principal Scientist Alex Klimowicz and Indica Labs CSO Kate Lillard to present at Pathology Visions Boston
October 2, 2015
Discoveries from the field: Expediting drug developments and clinical trials with digital pathology and HALO image analysis
Alex Klimowicz, PhD, Principal Scientist, Boehringer Ingelheim Pharmaceuticals
Kate Lillard Tunstall, PhD, CSO, Indica Labs
In this 60-minute presentation, our speakers will detail how the HALO image analysis platform has been used to analyze biomarkers in translational research and drug development, respectively. So please join us October Tuesday 13th at 8 a.m. in the Carlton Ballroom at the Westin Waterfront Hotel, at the Pathology Visions Conference.